A quarterly report on EDC’s expenditure, as well as, retention or designation of persons or organizations to engage in lobbying or lobbying activities before the council or any member thereof, the city planning commission, a borough president, a borough board or a community board.
A quarterly report on EDC’s expenditure, as well as, retention or designation of persons or organizations to engage in lobbying or lobbying activities before the council or any member thereof, the city planning commission, a borough president, a borough board or a community board.
A quarterly report on EDC’s expenditure, as well as, retention or designation of persons or organizations to engage in lobbying or lobbying activities before the council or any member thereof, the city planning commission, a borough president, a borough board or a community board.
A quarterly report on EDC’s expenditure, as well as, retention or designation of persons or organizations to engage in lobbying or lobbying activities before the council or any member thereof, the city planning commission, a borough president, a borough board or a community board.
A quarterly report on EDC’s expenditure, as well as, retention or designation of persons or organizations to engage in lobbying or lobbying activities before the council or any member thereof, the city planning commission, a borough president, a borough board or a community board.
A quarterly report on EDC’s expenditure, as well as, retention or designation of persons or organizations to engage in lobbying or lobbying activities before the council or any member thereof, the city planning commission, a borough president, a borough board or a community board.
Section 23-1202 of the New York City Administrative Code requires the Chief Privacy Officer to submit to the Speaker of the City Council, and make available online, a quarterly report containing an anonymized compilation or summary of certain disclosures of identifying information.
Report including (1) the number of opioid antagonists available; (2) the number of staff trained to administer; (3) the number of instances during the quarter it was administered; and (4) the number of instances in which the patient responded to the administration of an opioid antagonist.
Report including (1) the number of opioid antagonists available; (2) the number of staff trained to administer; (3) the number of instances during the quarter it was administered; and (4) the number of instances in which the patient responded to the administration of an opioid antagonist.